Mediso Extends the Preclinical Portfolio by 3T and 7T MRI, Via a New Strategic Collaboration

Corporate Breaking News

Home : Mediso Extends the Preclinical Portfolio by 3T and 7T MRI, Via a New Strategic Collaboration

Oct 20 2014	Mediso Extends the Preclinical Portfolio by 3T and 7T MRI, Via a New Strategic Collaboration
GÖTEBORG, Sweden, October 20, 2014 /PRNewswire/ -- Mediso Ltd announced today at the annual congress of the European Association of Nuclear Medicine the launch of new MRI subsystems with 3 and 7 Tesla field strength. This cryogen-free based technology is to be integrated into the...


Source:http://www.prnewswire.com/news-releases/mediso-extends-the-preclinical-portfolio-by-3t-and-7t-mri-via-a-new-strategic-collaboration-279801822.html

Related News
» E FUN Redefines Windows 2-in-1 Tablet Category with New 10.1" Nextbook » StackIQ Closes Series B Funding Amidst Explosive Demand for Web-Scale IT Automation From Major Enterprise Customers